Worms have tremendous therapeutic potential.

Decades of pre-clinical evidence has shown that worms can treat many disease, including the following:

•EOSINOPHILIC ESOPHAGITIS

•ASTHMA

•ULCERATIVE COLITIS

•CROHNS DISEASE

•MULTIPLE SCLEROSIS

•LUPUS

•RHEUMATOID ARTHRITIS

•…

Millions of patients continue to suffer from these debilitating diseases, which have multi-billion dollar market potential. Despite this, not a single worm-derived molecule has been taken into clinic.

HOLOCLARA is the first to mine worm-derived small molecules and develop patent-protected, chemistry-driven programs for FDA approval, with our first molecule heading to clinic in 2024.